Heimark, Sondre
Mariampillai, Julian E.
Narkiewicz, Krzysztof
Nilsson, Peter M.
Kjeldsen, Sverre E.
Article History
Received: 14 February 2018
Accepted: 23 March 2018
First Online: 16 April 2018
Compliance with Ethical Standards
:
: No funding has been received in support of writing this article.
: The two first authors have no conflict of interest to disclose. Peter M Nilsson has received speaking honoraria from Novo Nordisk, Merck, AstraZeneca and Boehringer-Ingelheim over past 3 years. Krzysztof Narkiewicz has received speaking honoraria from Berlin-Chemie/Menarini, Egis, Gedeon Richter, Krka and Servier. Sverre E. Kjeldsen has within the past 3 years received speaking honoraria from Bayer, MSD, Sanofi and Takeda.
: This article does not contain data derived by any current studies with human participants performed by any of the authors. The clinical studies mentioned were provided with specific ethical approval.